Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
13 Leser
Artikel bewerten:
(0)

Live Longer, Live Well

LONDON, October 27, 2014 /PRNewswire/ --

New philanthropic fund for research on ageing and health

British and American scientists met politicians and philanthropists at a reception in the House of Lords today (27 October 2014), to appeal for funds to support research into the biology of the ageing process.

It is imperative that we invest in fundamental biological research to ensure that the ageing population worldwide can remain healthy, and avoid the frailty and decline all too common among our older people today. Currently, potential donors cannot easily support such research in the UK. To meet this need, and help to turn recent research developments into clinical reality, the British Society for Research on Ageing (BSRA) announced that it would solicit donations to support crucial biomedical research. The initial funding target has been set at £700,000 which will be used to train the very best young scientists.

At the reception, guests heard that biological research is already yielding interventions in, or close to, the clinic which could rapidly improve health and dramatically cut healthcare costs.

Professor Richard Faragher, of the BSRA said:"Good health is key to a happy old age.The science of ageing has reached a point at which small amounts of carefully targeted funding will yield great social returns. The time to act is now."

On making the first donation, Mark R. Collins of the US Glenn Foundation for Medical Research said: "It is a privilege to support the British Society for Research on Ageing in its efforts to extend the healthy years of life. We are confident that British donors will join us in supporting this important initiative."

Notes to the editor:

The following organisations are co-ordinating this international collaboration:

The British Society for Research on Ageing (BSRA) is the oldest scientific society in the world promoting research aimed at achieving a healthy old age. It publishes a journal called Biogerontology. Website: http://www.bsra.org.uk. Its members include many of the greatest scientists in the world interested in the biology of the ageing process.

en.wikipedia.org/wiki/British_Society_for_Research_on_Ageing

The Glenn Foundation for Medical Research was founded in 1965 by Paul F. Glenn to extend the healthy productive years of life through research on the mechanisms of biological ageing. Website: glennfoundation.org

The American Federation forAgingResearch (AFAR) has supported the science of healthier ageing since its foundation in 1981. AFAR has played a major role in advancing knowledge of ageing and mechanisms of age-related disease by providing grants to more than 2,800 talented scientists. Website: http://www.afar.org

For more information, or for media interviews, please contact:

Professor Richard Faragher: +44-(0)797-097-3842; rgaf@brighton.ac.uk (primary contact)

Dr James Brown: +44-(0)7707-976070; J.E.P.BROWN@aston.ac.uk

Dr David Weinkove: +44-(0)7981-993-912; david.weinkove@durham.ac.uk

Dr Jill Saffrey: +44-(0)7825-313976; jill.saffrey@open.ac.uk

Presentations from the event can be found at http://www.bsra.org.uk.

livelongerlivewell

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.